<DOC>
	<DOCNO>NCT00978627</DOCNO>
	<brief_summary>This trial conduct Europe , Oceania , United States America ( USA ) . The aim clinical trial compare NN5401 ( insulin degludec/insulin aspart ( IDegAsp ) ) insulin detemir ( IDet ) plus insulin aspart patient type 1 diabetes ( main period ) follow extension period compare long-term safety NN5401 plus insulin aspart insulin detemir plus insulin aspart . The main period register internally Novo Nordisk NN5401-3594 extension period register NN5401-3645 .</brief_summary>
	<brief_title>Comparison NN5401 Plus Insulin Aspart With Insulin Detemir Plus Insulin Aspart Type 1 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin degludec , insulin aspart drug combination</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Insulin Detemir</mesh_term>
	<mesh_term>Insulin Aspart</mesh_term>
	<mesh_term>Insulin , Long-Acting</mesh_term>
	<criteria>FOR THE MAIN TRIAL , NN54013594 : Type 1 diabetes mellitus least 12 month Ongoing daily treatment insulin ( basal bolus regimen , premix insulin regimen , self mix regimen ) least 12 month HbA1c 7.010.0 % ( inclusive ) BMI ( Body Mass Index ) equal 35.0 kg/m^2 FOR THE EXTENSION TRIAL , NN54013645 : The subject must complete sixmonth treatment period trial NN54013594 FOR THE MAIN TRIAL , NN54013594 : Treatment insulin regimens insulin basal bolus regimen/premix insulin regimen/self mix regimen within 3 month Cardiovascular disease within last 6 month Uncontrolled treated/untreated severe hypertension Pregnancy , breastfeeding , intention become pregnant use adequate contraceptive measure accord local requirement Cancer medical history cancer FOR THE EXTENSION TRIAL , NN54013645 : Anticipated significant lifestyle change trial Pregnancy , breastfeeding , intention become pregnant use adequate contraceptive measure</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>